These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 484541)

  • 21. Enzyme deficiencies in the porphyrias.
    Kramer S; Becker DM; Viljoen JD
    Br J Haematol; 1977 Dec; 37(4):439-45. PubMed ID: 603772
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies in porphyria IX: Detection of the gene defect of erythropoietic protoporphyria in mitogen-stimulated human lymphocytes.
    Sassa S; Zalar GL; Poh-Fitzpatrick MB; Kappas A
    Trans Assoc Am Physicians; 1979; 92():268-76. PubMed ID: 549253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accumulation of protoporphyrin IX from delta-aminolevulinic acid in bovine skin fibroblasts with hereditary erythropoietic protoporphyria. A gene-dosage effect.
    Sassa S; Schwartz S; Ruth G
    J Exp Med; 1981 May; 153(5):1094-101. PubMed ID: 6788885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ferrochelatase consisting of wild-type and mutated subunits from patients with a dominant-inherited disease, erythropoietic protoporphyria, is an active but unstable dimer.
    Ohgari Y; Sawamoto M; Yamamoto M; Kohno H; Taketani S
    Hum Mol Genet; 2005 Jan; 14(2):327-34. PubMed ID: 15574461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability.
    Barman-Aksözen J; Minder EI; Schubiger C; Biolcati G; Schneider-Yin X
    Blood Cells Mol Dis; 2015 Jan; 54(1):71-7. PubMed ID: 25179834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythrocyte porphyrinogen carboxy-lyase activity in porphyria cutanea tarda and certain other human porphyrias.
    Ríos de Molina MC; Wainstok de Calmanovici R; Grinstein M; San Martín de Viale LC
    Clin Chim Acta; 1980 Dec; 108(3):447-56. PubMed ID: 7471475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunochemical studies of ferrochelatase protein: characterization of the normal and mutant protein in bovine and human protoporphyria.
    Straka JG; Hill HD; Krikava JM; Kools AM; Bloomer JR
    Am J Hum Genet; 1991 Jan; 48(1):72-8. PubMed ID: 1985464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ferrochelatase activity in human lymphocytes: effect of storage on haem formation.
    Tovey JA; Elder GH
    Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():80-1. PubMed ID: 2310162
    [No Abstract]   [Full Text] [Related]  

  • 29. [Decreased heme synthetase activity in erythroblasts in two patients with erythropoietic protoporphyria (author's transl)].
    Kaneko K; Sanada M; Imaizumi S; Koike T; Miyashita M; Shibata A
    Rinsho Ketsueki; 1981 Dec; 22(12):2023-33. PubMed ID: 7345186
    [No Abstract]   [Full Text] [Related]  

  • 30. Ferrochelatase and N-alkylated porphyrins.
    Cole SP; Marks GS
    Mol Cell Biochem; 1984 Sep; 64(2):127-37. PubMed ID: 6390167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inherited enzymatic defect in porphyria variegata.
    Deybach JC; de Verneuil H; Nordmann Y
    Hum Genet; 1981; 58(4):425-8. PubMed ID: 7327566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity.
    Barman-Aksoezen J; Girelli D; Aurizi C; Schneider-Yin X; Campostrini N; Barbieri L; Minder EI; Biolcati G
    J Inherit Metab Dis; 2017 May; 40(3):433-441. PubMed ID: 28185024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amelioration of the metabolic defect in erythropoietic protoporphyria by expression of human ferrochelatase in cultured cells.
    Mathews-Roth MM; Michel JL; Wise RJ
    J Invest Dermatol; 1995 Apr; 104(4):497-9. PubMed ID: 7706765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel splicing mutation in the ferrochelatase gene responsible for erythropoietic protoporphyria.
    Wang X; Poh-Fitzpatrick M; Piomelli S
    Biochim Biophys Acta; 1994 Oct; 1227(1-2):25-7. PubMed ID: 7918679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic value of cord blood analysis in erythropoietic protoporphyria: the 'Duesseldorf Cord Blood Study'.
    Hanneken S; Siegesmund M; Bolsen K; Gardlo K; Neumann NJ
    Photodermatol Photoimmunol Photomed; 2010 Feb; 26(1):7-9. PubMed ID: 20070832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The enzymatic defects in porphyria cutanea tarda and variegate porphyria.
    Kushner JP
    Acta Derm Venereol Suppl (Stockh); 1982; 100():51-6. PubMed ID: 6962633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The porphyrias: recent advances.
    Hindmarsh JT
    Clin Chem; 1986 Jul; 32(7):1255-63. PubMed ID: 3521939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies in porphyria. VII. Induction of uroporphyrinogen-I synthase and expression of the gene defect of acute intermittent porphyria in mitogen-stimulated human lymphocytes.
    Sassa S; Zalar GL; Kappas A
    J Clin Invest; 1978 Feb; 61(2):499-508. PubMed ID: 621286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bovine protoporphyria: the first nonhuman model of this hereditary photosensitizing disease.
    RUTH GR; Schwartz S; Stephenson B
    Science; 1977 Oct; 198(4313):199-201. PubMed ID: 905823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease.
    Tutois S; Montagutelli X; Da Silva V; Jouault H; Rouyer-Fessard P; Leroy-Viard K; Guénet JL; Nordmann Y; Beuzard Y; Deybach JC
    J Clin Invest; 1991 Nov; 88(5):1730-6. PubMed ID: 1939658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.